Multiplexed
diagnostics is the process of simultaneous detection of multiple biomarkers in
a single sample. Multiplexed assays are gaining high acceptance in clinical
diagnostic research as they provide benefit of analyzing several biomarkers
simultaneously and with better predictive value than that with single analyte.
Adoption of multiplexing methods in immunoassays, genomics and protein analysis
are gaining potential application in the field of research while gathering
acceptance in research, laboratory investigations.
Browse Full Report with
TOC: http://www.transparencymarketresearch.com/multiplexed-diagnostics-market.html
The
global multiplexed diagnostics market is categorized as follows:
Application and
products:
·
Infectious
disease diagnostics
·
Pre/post
natal genetic screening
·
Oncology
diagnostics
·
Pharmcogenomics
and other applications
·
Identity
diagnostics
·
Others
Technology
·
Forward-phase
multiplexed immunoassays
·
Reverse-phase
multiplexed immunoassays
·
Planar
microarrays
·
Bead‐based microarrays
·
Others
At
present, North America dominates the global multiplexed diagnostics market and
is followed by Europe. Emerging economies of Asia-Pacific, Middle East and
Latin America are also expected to undergo rapid growth in this market owing to
benefits such as time saving and cost reduction in diagnostics.
Some
of the major factors driving the market for multiplexed diagnostics include
high demand for improving diagnosis and predicting treatment response. Other
factors propelling the market growth are technological advances in multivariate
diagnosis methods, continuous addition of novel and innovative biomarkers
and an intensive effort to clinically validate these multiplexed diagnostic
tests. However, dicey reimbursement policies, vague business models and ever
increasing competition among the current market players may pose a challenge to
the multiplexed diagnostics market.
Some
of the key players contributing to the multiplexed diagnostics market include
Abbott Laboratories, Inc., Agilent Technologies, Inc., BioMérieux SA, Bio-Rad
Laboratories, Inc., ELITech Group, CytoCore, Inc., Life Technologies
Corporation, Genzyme Corporation, GE Healthcare, Novartis Diagnostics, Hologic
Inc., Illumina, Inc., MiraiBio, Inc., Myriad Genetics QIAGEN N.V, Roche
Diagnostics, Quest Diagnostics Inc., Tecan Group Ltd. and Siemens Healthcare
Diagnostics, Inc.
This
research report analyzes this market depending on its market segments, major
geographies, and current market trends. Geographies analyzed under this
research report include
·
North
America
·
Asia
Pacific
·
Europe
·
Rest
of the World
This
report provides comprehensive analysis of
·
Market
growth drivers
·
Factors
limiting market growth
·
Current
market trends
·
Market
structure
·
Market
projections for upcoming years
This
report is a complete study of current trends in the market, industry growth
drivers, and restraints. It provides market projections for the coming years.
It includes analysis of recent developments in technology, Porter’s five force
model analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
More
Reports On Medical Devices Market: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
About us
Transparency
Market Research (TMR) is a market intelligence company providing global
business research reports and consulting services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking insights
for thousands of decision-makers.
TMR’s
experienced team of analysts, researchers, and consultants use proprietary data
sources along with various tools and techniques to gather and analyze
information.Our business offerings represent the latest and the most reliable
information which is indispensable for businesses to sustain their competitive
edge.
Download PDF File: MultiplexedDiagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends AndForecast, 2013 - 2019
Contact Us
Corporate
Office:
State
Tower,
90
State Street,
Suite
700,
Albany
NY - 12207
United
States
Tel:
+1-518-618-1030
0 comments:
Post a Comment